P7

General Information


DRACP ID  DRACP00403

Peptide Name   P7

Sequence  PLLQATLGGGS

Sequence Length  11

UniProt ID  Not available

PubChem CID  Not available

Origin  No information found in the references

Type  Native peptide

Classification

  

Active ACP Cancer targeted peptides Membrane-targeted



Activity Information


Cell Line Disease Cancer Classified Activity Assay Testing Time Literature
B16-F10 Mouse melanoma Carcinoma IC50=1 µM WST-1 assay 48 h 1

Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Not available

Target  Angiogenic factor FGF2

Affinity  Not available

Mechanism  Not available

Nature  Anticancer; Antiproliferative; Antiangiogenic



Structure Information


PDB ID  Not available

Predicted Structure  DRACP00403

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Free

C-terminal Modification  Free

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C44H76N12O15

Absent amino acids  CDEFHIKMNRVWY

Common amino acids  GL

Mass  119172

Pl  6.11

Basic residues  0

Acidic residues  0

Hydrophobic residues  4

Net charge  0

Boman Index  788

Hydrophobicity  49.09

Aliphatic Index  115.45

Half Life 
  Mammalian: 20 hour
  Yeast: 30 min
  E.coli: >10 hour

Extinction Coefficient cystines  0

Absorbance 280nm  0

Polar residues  5

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 22481251

Title  The FGF2-binding peptide P7 inhibits melanoma growth in vitro and in vivo

Doi 10.1007/s00432-012-1201-7

Year  2012

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DRACP is developed by Dr.Zheng's team.